Silibinin: an old drug for hematological disorders
Hai Zou(Shanghai Medical College of Fudan University), Dongsheng Huang(Zhejiang Provincial People's Hospital), Xingxing Zhu(University of Glasgow), Yuan Ma(Zhejiang Provincial People's Hospital), Guobing Zhang(Zhejiang Provincial People's Hospital), Yi Wu(Zhejiang Provincial People's Hospital)
Cited by 28
Related Papers
Fe<sub>3</sub>O<sub>4</sub>/Ag/Bi<sub>2</sub>MoO<sub>6</sub> Photoactivatable Nanozyme for Self‐Replenishing and Sustainable Cascaded Nanocatalytic Cancer Therapy
|Advanced Materials|2021|250
Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
|Scientific Reports|2016|138
Energy Metabolism Disorder as a Contributing Factor of Rheumatoid Arthritis: A Comparative Proteomic and Metabolomic Study
|PLoS ONE|2015|112
Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway
|Oncology Reports|2013|109
Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression
|Molecular Medicine Reports|2012|108